Neurocrine Biosciences, Inc.
Profit History
| Period | Revenue | Operating Income | Net Income |
|---|---|---|---|
| Jun 2010 | $4.6M | $-5.9M | $-5.2M |
| Sep 2010 | $14.4M | $2.5M | $3.3M |
| Mar 2011 | $12.5M | $1.9M | $2.9M |
| Jun 2011 | $12.2M | $1.1M | $2.0M |
| Sep 2011 | $41.6M | $30.4M | $31.4M |
| Dec 2011 | $11.1M | $447.0K | $1.3M |
| Mar 2012 | $11.3M | $-1.8M | $-886.0K |
| Jun 2012 | $10.6M | $-1.4M | $-501.0K |
| Sep 2012 | $9.4M | $-4.0M | $-3.1M |
| Dec 2012 | $21.9M | $8.6M | $9.5M |
| Mar 2013 | $730.0K | $-13.0M | $-12.1M |
| Jun 2013 | $730.0K | $-13.2M | $-12.2M |
| Sep 2013 | $729.0K | $-12.0M | $-11.1M |
| Dec 2013 | $730.0K | $-11.5M | $-10.6M |
| Mar 2014 | $0 | $-12.7M | $-11.8M |
| Jun 2014 | $0 | $-14.4M | $-13.4M |
| Sep 2014 | $0 | $-16.9M | $-15.9M |
| Dec 2014 | $0 | $-20.5M | $-19.4M |
| Mar 2015 | $19.8M | $-2.3M | $-1.2M |
| Jun 2015 | $0 | $-25.3M | $-24.0M |
| Sep 2015 | $0 | $-35.8M | $-34.4M |
| Dec 2015 | $0 | $-30.7M | $-29.3M |
| Mar 2016 | $15.0M | $-20.9M | $-19.3M |
| Jun 2016 | $0 | $-41.8M | $-40.3M |
| Sep 2016 | $0 | $-38.4M | $-36.9M |
| Dec 2016 | $0 | $-46.3M | $-44.7M |
| Mar 2017 | $0 | $-79.9M | $-78.3M |
| Jun 2017 | $6.3M | $-57.3M | $-60.0M |
| Sep 2017 | $60.8M | $-6.0M | $-11.1M |
| Dec 2017 | $94.5M | $11.8M | $6.9M |
| Mar 2018 | $71.1M | $-37.4M | $-41.8M |
| Jun 2018 | $96.9M | $-1.9M | $-5.9M |
| Sep 2018 | $151.8M | $54.3M | $50.8M |
| Dec 2018 | $131.5M | $21.8M | $18.1M |
| Mar 2019 | $138.4M | $-101.0M | $-102.1M |
| Jun 2019 | $183.5M | $34.4M | $51.3M |
| Sep 2019 | $222.1M | $90.1M | $53.8M |
| Dec 2019 | $244.1M | $48.8M | $34.0M |
| Mar 2020 | $237.1M | $58.9M | $37.4M |
| Jun 2020 | $302.4M | $76.6M | $79.6M |
| Sep 2020 | $258.5M | $-44.3M | $-57.6M |
| Dec 2020 | $247.9M | $71.8M | $347.9M |
| Mar 2021 | $236.6M | $31.5M | $32.1M |
| Jun 2021 | $288.9M | $62.8M | $42.3M |
| Sep 2021 | $296.0M | $44.5M | $22.5M |
| Dec 2021 | $312.0M | $-36.3M | $-7.3M |
| Mar 2022 | $310.6M | $3.1M | $13.9M |
| Jun 2022 | $378.2M | $54.7M | $-16.9M |
| Sep 2022 | $387.9M | $87.8M | $68.5M |
| Dec 2022 | $412.0M | $103.4M | $89.0M |
| Mar 2023 | $420.4M | $-114.2M | $-76.6M |
| Jun 2023 | $452.7M | $73.6M | $95.5M |
| Sep 2023 | $498.8M | $141.2M | $83.1M |
| Dec 2023 | $515.2M | $150.3M | $147.7M |
| Mar 2024 | $515.3M | $99.3M | $43.4M |
| Jun 2024 | $590.2M | $145.4M | $65.0M |
| Sep 2024 | $622.1M | $183.8M | $129.8M |
| Dec 2024 | $627.7M | $142.0M | $103.1M |
| Mar 2025 | $572.6M | $23.6M | $7.9M |
| Jun 2025 | $687.5M | $145.6M | $107.5M |
| Sep 2025 | $794.9M | $239.0M | $209.5M |
| Dec 2025 | $805.5M | $210.9M | $153.7M |
| Mar 2026 | $814.5M | $193.4M | $197.9M |
| Jun 2026 | $959.0M | $151.5M | $144.4M |